Phase III results announced of PETIT2 study of eltrombopag (Promacta™/Revolade™) in paediatric patients with chronic immune thrombocytopen
6/16/2014

GlaxoSmithKline (GSK) plc has announced the results from the Phase III PETIT2 study evaluating the efficacy of eltrombopag vs.

Men who eat processed red meat at higher risk of heart failure, death
6/16/2014

Men who eat moderate amounts of processed red meat may have an increased risk of incidence and death from heart failure, according to a study in Circulation: Heart Failure, an American Heart...

Nicotine in e-cigarettes and smoking cessation devices 'carcinogenic'
6/16/2014

Research into the carcinogenic properties of nicotine may have severe implications for popular smoking cessation devices such as e-cigarettes and nicotine patches.

Cellular makeup of glioblastoma more diverse than previously thought
6/16/2014

Scientists from the Broad Institute and Massachusetts General Hospital (MGH) have conducted a first-of-its-kind study that characterizes the cellular diversity within glioblastoma tumors from...

New therapies for brain infections and cancers likely following discovery of fungal protein that can cross blood-brain barrier
6/16/2014

In a remarkable series of experiments on a fungus that causes cryptococcal meningitis, a deadly infection of the membranes that cover the spinal cord and brain, investigators at UC Davis have...

Camel and llama antibodies act as guides to diseased cells
6/16/2014

The use of nanoparticles in cancer research is considered as a promising approach in detecting and fighting tumour cells.

Researchers uncover basis for health differences among Latinos
6/16/2014

In the most comprehensive genetic study of the Mexican population to date, researchers from UC San Francisco and Stanford University, along with Mexico's National Institute of Genomic Medicine...

Sunscreen alone 'not enough' to protect against melanoma
6/15/2014

New research finds that wearing sunscreen alone does not offer complete protection against DNA-damaging UV radiation, meaning there is still a significant risk of melanoma.

Added benefit for non-pretreated patients still not proven for ipilimumab in advanced melanoma:
6/15/2014

In two addenda, IQWiG conducted an assessment of study data on further comparator therapy and on updated data analysesIn early 2014, the German Institute for Quality and Efficiency in Health Care...

New Journal of Medical Imaging highlights improvements in imaging of retina, brain, breast, more
6/15/2014

The Journal of Medical Imaging (JMI) has launched, with freely accessible articles on new research on earlier and more accurate diagnosis and monitoring of cancer and other diseases, image quality...